Hepatology Communications

🚨GI/Hep Fellowships start next week‼️ @HepCommJournal has the 📑 you need to thrive 💫 #GIHepFellowshipBootcamp First up, you get a consult for a #LiverMass, ✅ out this review about benign liver masses❕ 📍Hemangiomas 📍FNH 📍Hepatic Adenomas 📍Cysts journals.lww.com/hepcomm/fullte…

EDITORIAL: journals.lww.com/hepcomm/fullte… Several important papers on the emotional burden of #cirrhosis in @HepCommJournal @SarahKhan9894 and @vinayjaha put them into context

📑 Multidisciplinary care for patients with #HCC is associated w ⬇️ mortality! ⭐️Increasingly important given the complexity of treatment decisions! #LiverTwitter #OncTwitter #RadsTwitter #OpenAccess journals.lww.com/hepcomm/Fullte…

Rising alcohol-associated liver disease–related mortality rates in the United States from 1999 to 2022 Evidence Corner by: @sniezenMD journals.lww.com/hepcomm/fullte…

📑 #Atorvastatin for patients with cirrhosis: an RCT❕ 🔴 No change in mortality 🔴 No change in hospitalization 🟢 ⬇️ systemic inflammation! 🟢 Effects on lipidomics #LiverTwitter journals.lww.com/hepcomm/fullte…

📑 Racial and ethnic differences and the role of unfavorable #SDoH across #steatotic liver disease subtypes in the US‼️ @OchoaAllemantMD, @jmarrero6713, and @serperm show the interplay between SLD subtypes, Hispanic ethnicity, and SDOH #LiverTwitter journals.lww.com/hepcomm/fullte…

📄 Nonselective beta-blockers may lead to stage 2 #AKI and waitlist mortality in child C cirrhosis‼️ ⚠️ Use caution when using NSBBs in decompensated cirrhosis #LiverTwitter #OpenAccess journals.lww.com/hepcomm/fullte…

Hey AI chatbot🤖, create patient educational material on #cirrhosis❕ Compared to human educational materials, comparable: 📝Readability 📝Grade Level 📝Understandability 📝Accuracy @faruq_pradhan journals.lww.com/hepcomm/fullte…

📑Risk of HCC ⬇️ in HBV-related patients with cirrhosis acquired recompensation‼️ 🔑 Patients with HBV-related decompensated cirrhosis who experienced recompensation had a ⬇️ risk of HCC comparable to those with compensated cirrhosis #LiverTwitter journals.lww.com/hepcomm/fullte…

📑 New follow-up data from the HOPE-ECD-DBD RCT looks at the long-term outcomes of #HOPE treated allografts in #liver transplantation‼️       💡Machine perfusion may reduce late-onset morbidity and improve graft survival in ECD livers‼️ #LiverTwitter journals.lww.com/hepcomm/fullte…

Do behavioral economic interventions improve HCC surveillance⁉️ Ultrasound Surveillance: 🔸Usual Care: 26.6% 😞 🔸Letter➕Order: 54.5%‼️ 🔸Letter➕Order➕💵: 54.1% 📣 Outreach is effective! journals.lww.com/hepcomm/fullte…

📑 A randomized study of ceftriaxone to 🛑 infections in hospitalized patients w cirrhosis⁉️ 3️⃣0️⃣ patients w cirrhosis & MELD 18+ randomized to CTX or placebo: 🔹No difference in incidence of infection, ☠️, or 🏥length of stay. 🔹Larger studies needed❕ journals.lww.com/hepcomm/fullte…

📑 The Edmonton Symptom Assessment System is a valid tool to assess symptom burden among patients with decompensated #cirrhosis ❕ 📋measures 10 symptoms 🕰️ ~1-2 minutes to complete 🌍available in >20 languages journals.lww.com/hepcomm/fullte…

📑 Immunologic landscape of human hepatic hemangiomas and epithelioid hemangioendotheliomas 📑 🔵 Human hepatic hemangioma & hepatic epitheloidhemangiothelioma differ in endothelial cell marker expression & in their entity-specific immunologic landscape journals.lww.com/hepcomm/fullte…

🚨 #GIHepFellowshipBootcamp was fun‼️ Good luck to all GI/Hep fellows starting tomorrow❕For all of your #liver questions, @HepCommJournal is here for you❕ journals.lww.com/hepcomm/pages/… #OpenAccess

🚨 Next 📑 for #GIHepFellowshipBootcamp covers #WilsonDisease‼️ ⭐️ Epidemiology ⭐️ Diagnosis ⭐️ Treatment journals.lww.com/hepcomm/fullte…

🚨Next ⬆️ #GIHepFellowshipBootcamp, #DILI from Complementary & Alternative Med (CAM)‼️ A 📈 cause of liver injury❕🌿 🔎 Get a full history 🔎 Assess degree/pattern of injury 🔎 Rule-out other causes 🔎 Consider biopsy if needed ⭐️ Great approach figure👇 journals.lww.com/hepcomm/fullte…

🚨 Next ⬆️ in #GIHepFellowshipBootcamp, you get a consult 📟: “Can this patient with #cirrhosis undergo surgery 🔪⁉️” ☑️out this 🧵 for a deep dive into surg risk assessment in cirrhosis❕ journals.lww.com/hepcomm/fullte…

🚨 #GIHepFellowshipBootcamp continues‼️ Your 📟 goes off at 3am, a patient is having an EV bleed 😳 Relax 🧘‍♀️, you got this❕This 📑 will teach you the 🔑s to manage EV🩸❕ 🩸Resuscitation 🩸Vasoactive Tx 🩸Antibiotics 🩸Endoscopy 🩸Preempt. TIPS❓ journals.lww.com/hepcomm/fullte…

🚨 Liver Biopsy remains a 🔑 tool in our 🧰 , so #GIHepFellowshipBootcamp is here to get you ready to understand: 💉Utility of biopsy across conditions❕ 💉Biopsy histologic characteristics❕ 💡The table below is GOLD 🏆 journals.lww.com/hepcomm/fullte…

Very excited to share my work in @HepCommJournal ‼️ Read our 9⃣ key recommendations for future SLD patient education: journals.lww.com/hepcomm/fullte… Huge thank you to Dr. Khalili @UCSF, the liver clinic @ZSFGCare, and my MD/MPH faculty @TuftsMedSchool & @TuftsPH